Press Releases

Roswell Park Comprehensive Cancer Center today announced plans for an expanded Amherst location at Park Club Lane, to be named for longtime supporter Scott Bieler in recognition of a significant gift made to the Roswell Park Alliance Foundation.

One of the most influential and accomplished figures in the field of cancer immunotherapy has returned to his Western New York roots to take on leadership roles in both research and clinical care at Roswell Park Comprehensive Cancer Center. Renier Brentjens, MD, PhD, will join Roswell Park in September as Deputy Director, The Katherine Anne Gioia Endowed Chair in Cancer Medicine, Chair of the Department of Medicine and Professor of Oncology in the Departments of Medicine and Immunology.

Elevating a highly accomplished finance professional to an expanded role with additional responsibilities, Roswell Park Comprehensive Cancer Center announces the promotion of Todd Maier, CPA, to Vice President of Finance.

At the American Head & Neck Society's 10th International Conference on Head and Neck Cancer, Roswell Park teams are presenting new research on the basic science supporting new treatments as well as opportunities to improve the early and accurate diagnosis of head/neck malignancies.

A research team led by Fumito Ito, MD, PhD, FACS, reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immunotherapy — dendritic-cell (DC)  treatment vaccines.

Nearly two decades ago, first responders from across New York State answered the call for help when thousands of people were killed and injured in the terrorist attacks of Sept. 11, 2001. A new program at Roswell Park Comprehensive Cancer Center will make sure these brave police officers, firefighters and emergency personnel don’t need to cross the state to protect themselves from the long-term health effects they may still be dealing with because of their 9/11-related service.

Two Roswell Park experts were invited to present new insights on treatment of gastroesophageal cancers during the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021. Both highlighted easily adoptable methods that may help other clinicians to provide care supporting improved patient outcomes.

Even as the COVID-19 pandemic took hold, Roswell Park Comprehensive Cancer Center scientists continued to draw support for their innovative research proposals, garnering more than $34 million in competitive grants from government agencies and private funders. These recent grants fund efforts to improve outcomes for patients with some of the most challenging cancer types — including triple-negative breast cancer, pancreatic cancer and head and neck cancers — and to advance what we know about the impact of COVID-19 in cancer patients.